Abstract
Fragility fractures are increasingly recognized as a complication of both type 1 and type 2 diabetes, with fracture risk that increases with disease duration and poor glycemic control. Yet the identification and management of fracture risk in these patients remains challenging. This review explores the clinical characteristics of bone fragility in adults with diabetes and highlights recent studies that have evaluated bone mineral density (BMD), bone microstructure and material properties, biochemical markers, and fracture prediction algorithms (i.e., FRAX) in these patients. It further reviews the impact of diabetes drugs on bone as well as the efficacy of osteoporosis treatments in this population. We finally propose an algorithm for the identification and management of diabetic patients at increased fracture risk.
Original language | English |
---|---|
Pages (from-to) | 2585-2596 |
Number of pages | 12 |
Journal | Osteoporosis International |
Volume | 29 |
Issue number | 12 |
DOIs | |
Publication status | Published - 01-12-2018 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Endocrinology, Diabetes and Metabolism
Cite this
}
Diagnosis and management of bone fragility in diabetes : an emerging challenge. / on behalf of the Bone and Diabetes Working Group of IOF.
In: Osteoporosis International, Vol. 29, No. 12, 01.12.2018, p. 2585-2596.Research output: Contribution to journal › Review article
TY - JOUR
T1 - Diagnosis and management of bone fragility in diabetes
T2 - an emerging challenge
AU - on behalf of the Bone and Diabetes Working Group of IOF
AU - Ferrari, S. L.
AU - Abrahamsen, B.
AU - Napoli, N.
AU - Akesson, K.
AU - Chandran, M.
AU - Eastell, R.
AU - El-Hajj Fuleihan, G.
AU - Josse, R.
AU - Kendler, D. L.
AU - Kraenzlin, M.
AU - Suzuki, A.
AU - Pierroz, D. D.
AU - Schwartz, A. V.
AU - Leslie, W. D.
AU - Ferrari, S. L.
AU - Ardawi, M. S.M.
AU - Cooper, C.
AU - Mithal, A.
PY - 2018/12/1
Y1 - 2018/12/1
N2 - Fragility fractures are increasingly recognized as a complication of both type 1 and type 2 diabetes, with fracture risk that increases with disease duration and poor glycemic control. Yet the identification and management of fracture risk in these patients remains challenging. This review explores the clinical characteristics of bone fragility in adults with diabetes and highlights recent studies that have evaluated bone mineral density (BMD), bone microstructure and material properties, biochemical markers, and fracture prediction algorithms (i.e., FRAX) in these patients. It further reviews the impact of diabetes drugs on bone as well as the efficacy of osteoporosis treatments in this population. We finally propose an algorithm for the identification and management of diabetic patients at increased fracture risk.
AB - Fragility fractures are increasingly recognized as a complication of both type 1 and type 2 diabetes, with fracture risk that increases with disease duration and poor glycemic control. Yet the identification and management of fracture risk in these patients remains challenging. This review explores the clinical characteristics of bone fragility in adults with diabetes and highlights recent studies that have evaluated bone mineral density (BMD), bone microstructure and material properties, biochemical markers, and fracture prediction algorithms (i.e., FRAX) in these patients. It further reviews the impact of diabetes drugs on bone as well as the efficacy of osteoporosis treatments in this population. We finally propose an algorithm for the identification and management of diabetic patients at increased fracture risk.
UR - http://www.scopus.com/inward/record.url?scp=85051441673&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85051441673&partnerID=8YFLogxK
U2 - 10.1007/s00198-018-4650-2
DO - 10.1007/s00198-018-4650-2
M3 - Review article
C2 - 30066131
AN - SCOPUS:85051441673
VL - 29
SP - 2585
EP - 2596
JO - Osteoporosis International
JF - Osteoporosis International
SN - 0937-941X
IS - 12
ER -